Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rubius Therapeutics Inc (NQ: RUBY )

8.020 -3.160 (-28.26%)
Official Closing Price Updated: 7:58 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Rubius Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Cellarity, a life sciences company founded by Flagship Pioneering to develop a new method of drug discovery targeting the cell, announced today that it raised $123 million in Series B financing. The... 
From PR Newswire
Rubius Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MGNX Market News ITOS
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags BMO MATX MTDR
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags NUVA LMAT AERI
From Benzinga
Rubius Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
From GlobeNewswire News Releases
Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
From GlobeNewswire News Releases
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VRTX RUBY RDHL
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 92 companies achieved new highs for the year. Interesting Highlights: Abbott ... 
Tags UI SINO CGC
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech ILMN Earnings
From Benzinga
98 Biggest Movers From Yesterday
Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares jumped 537.5% to close at $25.50 on Wednesday after the company priced ... 
Tags UONE JAN CVM
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Sorrento Therapeutics (NASDAQ:SRNE) stock increased by 33.3% to $13.89 during Wednesday's regular session. ... 
Tags BZI/TFM TTOO Market News
From Benzinga
RUBY Crosses Above Average Analyst Target
In recent trading, shares of Rubius Therapeutics Inc (RUBY) have crossed above the average analyst 12-month target price of $9.33, changing hands for $9.53/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
Rubius Therapeutics Provides Operational Update and Outlines 2021 Objectives at the 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Rubius Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
68 Biggest Movers From Yesterday
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares jumped 82% to close at $22.75 on Tuesday after the company agreed to be ... 
Tags CREX AVXL METX
From Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Prevail Therapeutics Inc. (NASDAQ: PRVL) shares climbed 83.5% to $22.93 after the company agreed to be acquired by Eli ... 
Tags OPNT Benzinga VERU
From Benzinga
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
Financialnewsmedia.com News Commentary 
From PR Newswire
70 Biggest Movers From Yesterday
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares climbed 95.1% to close at $58.38 on Monday after the company reported ... 
Tags BRPA PRLD GLSI
From Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT) stock increased by 38.38% to $11.5 during Monday's after-market session. Opiant ... 
Tags CWBR General RUBY
From Benzinga
Noteworthy Monday Option Activity: RUBY, LGND, FIXX
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Rubius Therapeutics Inc (RUBY), where a total volume of 9,633 contracts has been... 
Tags Stocks
From Market News Video
12 Healthcare Stocks Moving In Monday's Intraday Session
Gainers Arvinas (NASDAQ:ARVN) shares rose 88.77% to $56.5 during Monday's regular session. The current volume of ... 
Tags Markets TLGT Intraday Update
From Benzinga
52 Stocks Moving In Monday's Mid-Day Session
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares jumped 103.4% to $60.87 after the company reported interim clinical data for its ... 
Tags ALGS SYBX XXII
From Benzinga
72 Biggest Movers From Friday
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ... 
Tags DIS SRG SNOA
From Benzinga
Rubius Therapeutics to Participate in Evercore ISI 3rd Annual HealthCONx Conference
From GlobeNewswire News Releases
Rubius Therapeutics Breaks Above 200-Day Moving Average - Bullish for RUBY
In trading on Monday, shares of Rubius Therapeutics Inc (RUBY) crossed above their 200 day moving average of $5.66, changing hands as high as $5.83 per share. Rubius Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
Rubius Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
From GlobeNewswire News Releases
Implied VBK Analyst Target Price: $260
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.